Women's Cancer News
Jul. 10, 2013

Only half of physicians follow cervical cancer prevention guidelines
Healio
Less than one-third of obstetrician-gynecologists vaccinate eligible patients against HPV and only half follow the cervical cancer prevention guidelines that were published in 2009, according to recent survey findings published in the American Journal of Preventive Medicine. The survey-based study included 366 obstetrician-gynecologists from the American Congress of Obstetricians and Gynecologists. Surveys evaluated sociodemographic characteristics, clinical practices and perceived barriers to HPV vaccination and cervical cancer screening.More

Are women meeting cancer-prevention recommendations? Not really
Oncology Nurse Advisor
Most women who reported eating a healthful diet and being physically active to ward off cancer were, in fact, not meeting the minimum recommendations for cancer prevention, according to recent survey findings. Approximately 200 women responded to a cross-sectional, national, random-digit-dialed telephone survey conducted by Jennifer Irvin Vidrine, Ph.D., of the Department of Health Disparities Research at The University of Texas MD Anderson Cancer Center in Houston, Texas, and colleagues. More

Catch ovarian cancer before the disease catches you
The Telegraph
The sad news that Pierce Brosnan's daughter, Charlotte Emily, has died of ovarian cancer at the age of 42 has put this oft-ignored disease on the news agenda. It is the fifth most common cancer in women, yet it is rarely in the headlines compared with, say, breast or cervical cancer. Ovarian cancer has been linked to certain genetic mutations that are also implicated in breast cancer; and the tragedy of Charlotte’s death was compounded by the fact that her mother Cassandra, Brosnan’s first wife, died of the same disease in 1991.More

Study: Rural women less likely to get preferred breast cancer treatment
HealthDay News via U.S. News & World Report
Breast cancer patients in rural areas of the United States are less likely than those in cities to receive recommended radiation therapy after having a lumpectomy, a new study finds. The analysis of data from nearly 350,000 California breast cancer patients treated between 1996 and 2008 revealed other differences in diagnosis and treatment between rural and urban patients, the researchers said.More

How aspirin might stem cancer
The New York Times
The use of aspirin and other nonsteroidal anti-inflammatory drugs significantly reduces the risk for cancer, but no one has been able to explain why. Now researchers have found that these drugs slow the accumulation of a type of DNA change called somatic genome abnormalities that lead to uncontrolled cell growth.More

Researchers develop MRI scan to detect cancer using sugar
Medical News Today
Researchers say they have developed a new way of detecting cancer by giving patients an injection of sugar before doing an MRI scan. Scientists from University College London have developed a technique they call glucose chemical exchange saturation transfer. The work, published in the journal Nature Medicine, is based on the fact that tumors consume a higher amount of glucose compared with healthy tissues, as a way of sustaining their growth.More

White blood cells may play role in spread of cancer
The Huffington Post
White blood cells, the body's defense against infection, could actually play a role in spreading cancer, according to a new study in animals. Scientists from the Research Institute of the McGill University Health Centre found that an infection defense "web" called the Neutrophils Extracellular Traps, which works by trapping harmful pathogens in the body, also seems to trap and activate cancer cells circulating in the body. By doing so, it makes the spread of cancer — or metastasis — more likely.More

Progestin Tx reasonably effective for early endometrial cancer
HealthDay News via Medical Xpress
Conservative management with oral progestin can be a reasonable treatment option for many patients with stage 1A endometrial cancer, according to research published in Obstetrics & Gynecology. Jeong-Yeol Park, M.D., Ph.D., from the University of Ulsan in Korea, and colleagues reviewed the medical records of 48 women — age 40 years or younger — with endometrioid adenocarcinoma of the uterus who were treated conservatively with oral progestin.More